» Authors » E Haffen

E Haffen

Explore the profile of E Haffen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 56
Citations 347
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Roux P, Frileux S, Vidal N, Aubin V, Belzeaux R, Courtet P, et al.
Eur Psychiatry . 2024 Nov; 67(1):e78. PMID: 39543921
Background: Quality of life is decreased in bipolar disorders (BD) and contributes to poor prognosis. However, little is known about the causal pathways that may affect it. This study aimed...
2.
Sleurs D, Speranza M, Etain B, Aouizerate B, Aubin V, Bellivier F, et al.
Eur Child Adolesc Psychiatry . 2024 May; 33(11):4029-4041. PMID: 38702455
Defining homogeneous subgroups of bipolar disorder (BD) is a major goal in personalized psychiatry and research. According to the neurodevelopmental theory, age at onset may be a key variable. As...
3.
Godin O, Olie E, Fond G, Aouizerate B, Aubin V, Bellivier F, et al.
Acta Psychiatr Scand . 2024 Jan; 149(3):207-218. PMID: 38268142
Introduction: Metabolic syndrome (MetS) is a cluster of components including abdominal obesity, hyperglycemia, hypertension, and dyslipidemia. MetS is highly prevalent in individuals with bipolar disorders (BD) with an estimated global...
4.
Vidal N, Brunet-Gouet E, Frileux S, Aouizerate B, Aubin V, Belzeaux R, et al.
Eur Neuropsychopharmacol . 2023 Sep; 77:67-79. PMID: 37741163
Bipolar disorders (BD) are characterized by cognitive impairment during the euthymic phase, to which treatments can contribute. The anticholinergic properties of medications, i.e., the ability of a treatment to inhibit...
5.
Samalin L, Arnould A, Boudieu L, Henry C, Haffen E, Drapier D, et al.
Encephale . 2022 Oct; 48(6):624-631. PMID: 36257849
Introduction: The perinatal period is associated with high risk of relapses in women with untreated bipolar disorder (BD) and can have significant consequences on foetal and child development. Valproate is...
6.
Leboyer M, Godin O, Llorca P, Aubin V, Bellivier F, Belzeaux R, et al.
J Affect Disord . 2022 Mar; 307:149-156. PMID: 35339569
Background: The FACE-BD cohort is an observational cohort of individuals with bipolar disorders (BD) who benefited from a systematic evaluation with evidence-based treatment recommendations and who were followed-up every year...
7.
Grillault Laroche D, Godin O, Dansou Y, Belzeaux R, Aouizerate B, Burte T, et al.
Eur Psychiatry . 2022 Jan; 65(1):e15. PMID: 35060460
Background: Psychiatric comorbidities and suicide attempts are highly prevalent in Bipolar Disorders (BD). We examined the associations between childhood maltreatment, psychiatric comorbidities, and suicide attempts, in terms of lifetime prevalence,...
8.
Javelot H, Meyer G, Becker G, Post G, Runge V, Pospieszynski P, et al.
Encephale . 2021 Dec; 48(3):313-324. PMID: 34876278
Anticholinergic properties are well known to prescribers, notably in mental health, as a therapeutic strategy for i.e. extrapyramidal syndrome but also as a source of numerous adverse side effects. Herein,...
9.
Javelot H, Straczek C, Meyer G, Gitahy Falcao Faria C, Weiner L, Drapier D, et al.
Encephale . 2021 Sep; 47(6):564-588. PMID: 34548153
The use of psychotropics during the COVID-19 pandemic has raised two questions, in order of importance: first, what changes should be made to pharmacological treatments prescribed to mental health patients?...
10.
Nobile B, Durand M, Olie E, Guillaume S, Moles J, Haffen E, et al.
Front Pharmacol . 2021 Mar; 12:615695. PMID: 33767623
At the time of writing (December 2020), coronavirus disease 2019 (COVID-19) has already caused more than one million deaths worldwide, and therefore, it is imperative to find effective treatments. The...